about
Fluvastatin for lowering lipidsChanges in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11.Potential and Limitations of Cochrane Reviews in Pediatric Cardiology: A Systematic Analysis.Effects of intensive pitavastatin therapy on glucose control in patients with non-ST elevation acute coronary syndromeAtorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling.Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Lipid-lowering efficacy of atorvastatin
@ast
Lipid-lowering efficacy of atorvastatin
@en
Lipid-lowering efficacy of atorvastatin
@nl
type
label
Lipid-lowering efficacy of atorvastatin
@ast
Lipid-lowering efficacy of atorvastatin
@en
Lipid-lowering efficacy of atorvastatin
@nl
prefLabel
Lipid-lowering efficacy of atorvastatin
@ast
Lipid-lowering efficacy of atorvastatin
@en
Lipid-lowering efficacy of atorvastatin
@nl
P2093
P2860
P1476
Lipid-lowering efficacy of atorvastatin
@en
P2093
James M Wright
Michael Tsang
Stephen P Adams
P2860
P304
P356
10.1002/14651858.CD008226.PUB3
P577
2015-03-12T00:00:00Z